Index by author

01 December 2011; volume 38, issue 6

A

  1. Abubakar, I.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.
    2. Pimpin, L. et al "Tuberculosis and HIV co-infection in European Union and European Economic Area countries." European Respiratory Journal 38.6 (2011): 1382-1392. Web. 17 Nov. 2019.

  2. Aburto, M.

    1. Esteban, C. et al "Development of a decision tree to assess the severity and prognosis of stable COPD." European Respiratory Journal 38.6 (2011): 1294-1300. Web. 17 Nov. 2019.

  3. Aizpiri, S.

    1. Esteban, C. et al "Development of a decision tree to assess the severity and prognosis of stable COPD." European Respiratory Journal 38.6 (2011): 1294-1300. Web. 17 Nov. 2019.

  4. Alfonso, H.

    1. Musk, A.W. et al "Predicting survival in malignant mesothelioma." European Respiratory Journal 38.6 (2011): 1420-1424. Web. 17 Nov. 2019.

  5. Amato-Gauci, A.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.
    2. Pimpin, L. et al "Tuberculosis and HIV co-infection in European Union and European Economic Area countries." European Respiratory Journal 38.6 (2011): 1382-1392. Web. 17 Nov. 2019.

  6. Ammit, A.J.

    1. Seidel, P. et al "IκBα glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES." European Respiratory Journal 38.6 (2011): 1444-1452. Web. 17 Nov. 2019.

  7. Anaya, E.

    1. Moffett, B.K. et al "Computed tomography measurements of parapneumonic effusion indicative of thoracentesis." European Respiratory Journal 38.6 (2011): 1406-1411. Web. 17 Nov. 2019.

  8. Ando, M.

    1. Hirata, T. et al "Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients." European Respiratory Journal 38.6 (2011): 1425-1430. Web. 17 Nov. 2019.

  9. Annesi-Maesano, I.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  10. Arnold, F.W.

    1. Moffett, B.K. et al "Computed tomography measurements of parapneumonic effusion indicative of thoracentesis." European Respiratory Journal 38.6 (2011): 1406-1411. Web. 17 Nov. 2019.

  11. Arostegui, I.

    1. Esteban, C. et al "Development of a decision tree to assess the severity and prognosis of stable COPD." European Respiratory Journal 38.6 (2011): 1294-1300. Web. 17 Nov. 2019.

  12. Assael, B.M.

    1. Bakker, E.M. et al "Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation." European Respiratory Journal 38.6 (2011): 1328-1335. Web. 17 Nov. 2019.

  13. Aurora, P.

    1. Sonnappa, S. et al "Relationship between past airway pathology and current lung function in preschool wheezers." European Respiratory Journal 38.6 (2011): 1431-1436. Web. 17 Nov. 2019.

B

  1. Badri, M.

    1. Whitelaw, A. et al "Comparative cost and performance of light-emitting diode microscopy in HIV–tuberculosis-co-infected patients." European Respiratory Journal 38.6 (2011): 1393-1397. Web. 17 Nov. 2019.

  2. Bakke, P.S.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  3. Bakker, E.M.

    1. Bakker, E.M. et al "Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation." European Respiratory Journal 38.6 (2011): 1328-1335. Web. 17 Nov. 2019.

  4. Baldelli, F.

    1. Pontali, E. et al "Tuberculosis and HIV co-infection: do we have a surveillance system in Europe?." European Respiratory Journal 38.6 (2011): 1258-1260. Web. 17 Nov. 2019.

  5. Barna, B.P.

    1. Kavuru, M.S. et al "An open-label trial of rituximab therapy in pulmonary alveolar proteinosis." European Respiratory Journal 38.6 (2011): 1361-1367. Web. 17 Nov. 2019.

  6. Bastardo, C.M.

    1. Sonnappa, S. et al "Relationship between past airway pathology and current lung function in preschool wheezers." European Respiratory Journal 38.6 (2011): 1431-1436. Web. 17 Nov. 2019.

  7. Beek, F.J.

    1. van Zeggeren, L. et al "High-resolution computed tomography and pulmonary function in children with common variable immunodeficiency." European Respiratory Journal 38.6 (2011): 1437-1443. Web. 17 Nov. 2019.

  8. Bergamaschi, A.

    1. Nordby, K-C. et al "Exposure to thoracic dust, airway symptoms and lung function in cement production workers." European Respiratory Journal 38.6 (2011): 1278-1286. Web. 17 Nov. 2019.

  9. Berglund, E.

    1. Puchelle, E. et al "Prof. Paul Sadoul, 1918–2011." European Respiratory Journal 38.6 (2011): 1245-1247. Web. 17 Nov. 2019.

  10. Bernard, A.

    1. Van Miert, E., A. Sardella, and A. Bernard. "Biomarkers of early respiratory effects in smoking adolescents." European Respiratory Journal 38.6 (2011): 1287-1293. Web. 17 Nov. 2019.

  11. Bonneterre, V.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

  12. Bowling, A.

    1. Jones, A.M. et al "Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples." European Respiratory Journal 38.6 (2011): 1486-1487. Web. 17 Nov. 2019.

  13. Brambilla, C.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

  14. Brambilla, E.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

  15. Braumann, K.M.

    1. Gruber, W., D.M. Orenstein, and K.M. Braumann. "Do responses to exercise training in cystic fibrosis depend on initial fitness level?." European Respiratory Journal 38.6 (2011): 1336-1342. Web. 17 Nov. 2019.

  16. Brauner, M.

    1. Nardi, A. et al "Stage IV sarcoidosis: comparison of survival with the general population and causes of death." European Respiratory Journal 38.6 (2011): 1368-1373. Web. 17 Nov. 2019.

  17. Brichon, P.Y.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

  18. Bright-Thomas, R.

    1. Gilchrist, F.J. et al "Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?." European Respiratory Journal 38.6 (2011): 1483-1486. Web. 17 Nov. 2019.
    2. Jones, A.M. et al "Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples." European Respiratory Journal 38.6 (2011): 1486-1487. Web. 17 Nov. 2019.

  19. Brillet, P-Y.

    1. Nardi, A. et al "Stage IV sarcoidosis: comparison of survival with the general population and causes of death." European Respiratory Journal 38.6 (2011): 1368-1373. Web. 17 Nov. 2019.

  20. Bush, A.

    1. Sonnappa, S. et al "Relationship between past airway pathology and current lung function in preschool wheezers." European Respiratory Journal 38.6 (2011): 1431-1436. Web. 17 Nov. 2019.

C

  1. Cabane, J.

    1. Tiev, K.P. et al "Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis." European Respiratory Journal 38.6 (2011): 1355-1360. Web. 17 Nov. 2019.

  2. Capelastegui, A.

    1. Esteban, C. et al "Development of a decision tree to assess the severity and prognosis of stable COPD." European Respiratory Journal 38.6 (2011): 1294-1300. Web. 17 Nov. 2019.

  3. Carlsson, L.M.S.

    1. Marshall, N.S. et al "Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study." European Respiratory Journal 38.6 (2011): 1349-1354. Web. 17 Nov. 2019.

  4. Carpagnano, G.E.

    1. Carpagnano, G.E. et al "Microsatellite alterations at 3p and 19q in EBC DNA of smokers: are they reversible after smoking cessation?." European Respiratory Journal 38.6 (2011): 1477-1480. Web. 17 Nov. 2019.

  5. Chanez, P.

    1. Gaga, M., G. Joos, and P. Chanez. "Prof. Philippe Godard, 1948–2011." European Respiratory Journal 38.6 (2011): 1248-1249. Web. 17 Nov. 2019.

  6. Checkley, W.

    1. Checkley, W. et al "Supplementation with vitamin A early in life and subsequent risk of asthma." European Respiratory Journal 38.6 (2011): 1310-1319. Web. 17 Nov. 2019.

  7. Choi, D-J.

    1. Park, J.S. et al "EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism." European Respiratory Journal 38.6 (2011): 1480-1482. Web. 17 Nov. 2019.

  8. Christian, P.

    1. Checkley, W. et al "Supplementation with vitamin A early in life and subsequent risk of asthma." European Respiratory Journal 38.6 (2011): 1310-1319. Web. 17 Nov. 2019.

  9. Chung, J-H.

    1. Park, J.S. et al "EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism." European Respiratory Journal 38.6 (2011): 1480-1482. Web. 17 Nov. 2019.

  10. Chung, K.F.

    1. Chung, K.F.. "Prof. John Guy Widdicombe, 1925–2011: an appreciation of an eminent respiratory physiologist." European Respiratory Journal 38.6 (2011): 1243-1244. Web. 17 Nov. 2019.

  11. Colonna, M.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

  12. Córdova, J.

    1. Sandoval, J. et al "Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension." European Respiratory Journal 38.6 (2011): 1343-1348. Web. 17 Nov. 2019.

  13. Cullen, M.

    1. Jones, A.M. et al "Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples." European Respiratory Journal 38.6 (2011): 1486-1487. Web. 17 Nov. 2019.

D

  1. Dalrymple, H.

    1. Kavuru, M.S. et al "An open-label trial of rituximab therapy in pulmonary alveolar proteinosis." European Respiratory Journal 38.6 (2011): 1361-1367. Web. 17 Nov. 2019.

  2. Dancer, R.C.A.

    1. Dancer, R.C.A., A.M. Wood, and D.R. Thickett. "Metalloproteinases in idiopathic pulmonary fibrosis." European Respiratory Journal 38.6 (2011): 1461-1467. Web. 17 Nov. 2019.

  3. Davids, V.

    1. Whitelaw, A. et al "Comparative cost and performance of light-emitting diode microscopy in HIV–tuberculosis-co-infected patients." European Respiratory Journal 38.6 (2011): 1393-1397. Web. 17 Nov. 2019.

  4. de Jong, P.A.

    1. van Zeggeren, L. et al "High-resolution computed tomography and pulmonary function in children with common variable immunodeficiency." European Respiratory Journal 38.6 (2011): 1437-1443. Web. 17 Nov. 2019.

  5. Dekker, T.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.

  6. de Klerk, N.H.

    1. Hollams, E.M. et al "Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study." European Respiratory Journal 38.6 (2011): 1320-1327. Web. 17 Nov. 2019.
    2. Musk, A.W. et al "Predicting survival in malignant mesothelioma." European Respiratory Journal 38.6 (2011): 1420-1424. Web. 17 Nov. 2019.

  7. Delling, L.

    1. Marshall, N.S. et al "Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study." European Respiratory Journal 38.6 (2011): 1349-1354. Web. 17 Nov. 2019.

  8. Delpech, V.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.
    2. Pimpin, L. et al "Tuberculosis and HIV co-infection in European Union and European Economic Area countries." European Respiratory Journal 38.6 (2011): 1382-1392. Web. 17 Nov. 2019.

  9. del Valle, K.

    1. Sandoval, J. et al "Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension." European Respiratory Journal 38.6 (2011): 1343-1348. Web. 17 Nov. 2019.

  10. de Nijs, S.B.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.

  11. Dheda, K.

    1. Whitelaw, A. et al "Comparative cost and performance of light-emitting diode microscopy in HIV–tuberculosis-co-infected patients." European Respiratory Journal 38.6 (2011): 1393-1397. Web. 17 Nov. 2019.
    2. Minion, J. et al "Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis." European Respiratory Journal 38.6 (2011): 1398-1405. Web. 17 Nov. 2019.

  12. Dinh-Xuan, A.T.

    1. Puchelle, E. et al "Prof. Paul Sadoul, 1918–2011." European Respiratory Journal 38.6 (2011): 1245-1247. Web. 17 Nov. 2019.
    2. Tiev, K.P. et al "Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis." European Respiratory Journal 38.6 (2011): 1355-1360. Web. 17 Nov. 2019.

  13. Doherty, C.J.

    1. Gilchrist, F.J. et al "Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?." European Respiratory Journal 38.6 (2011): 1483-1486. Web. 17 Nov. 2019.

  14. Drumright, L.N.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.
    2. Pimpin, L. et al "Tuberculosis and HIV co-infection in European Union and European Economic Area countries." European Respiratory Journal 38.6 (2011): 1382-1392. Web. 17 Nov. 2019.

  15. Duong-Quy, S.

    1. Tiev, K.P. et al "Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis." European Respiratory Journal 38.6 (2011): 1355-1360. Web. 17 Nov. 2019.

E

  1. Eagan, T.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  2. Eduard, W.

    1. Nordby, K-C. et al "Exposure to thoracic dust, airway symptoms and lung function in cement production workers." European Respiratory Journal 38.6 (2011): 1278-1286. Web. 17 Nov. 2019.

  3. Esteban, C.

    1. Esteban, C. et al "Development of a decision tree to assess the severity and prognosis of stable COPD." European Respiratory Journal 38.6 (2011): 1294-1300. Web. 17 Nov. 2019.

F

  1. Fell, A.K.M.

    1. Nordby, K-C. et al "Exposure to thoracic dust, airway symptoms and lung function in cement production workers." European Respiratory Journal 38.6 (2011): 1278-1286. Web. 17 Nov. 2019.

  2. Fens, N.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.

  3. Flight, W.

    1. Jones, A.M. et al "Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples." European Respiratory Journal 38.6 (2011): 1486-1487. Web. 17 Nov. 2019.

  4. Foschino Barbaro, M.P.

    1. Carpagnano, G.E. et al "Microsatellite alterations at 3p and 19q in EBC DNA of smokers: are they reversible after smoking cessation?." European Respiratory Journal 38.6 (2011): 1477-1480. Web. 17 Nov. 2019.

  5. France, M.

    1. Gilchrist, F.J. et al "Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?." European Respiratory Journal 38.6 (2011): 1483-1486. Web. 17 Nov. 2019.

  6. Franklin, P.

    1. Musk, A.W. et al "Predicting survival in malignant mesothelioma." European Respiratory Journal 38.6 (2011): 1420-1424. Web. 17 Nov. 2019.

  7. Fujiwara, Y.

    1. Hirata, T. et al "Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients." European Respiratory Journal 38.6 (2011): 1425-1430. Web. 17 Nov. 2019.

G

  1. Gaga, M.

    1. Gaga, M., G. Joos, and P. Chanez. "Prof. Philippe Godard, 1948–2011." European Respiratory Journal 38.6 (2011): 1248-1249. Web. 17 Nov. 2019.

  2. Gain, M.

    1. Tiev, K.P. et al "Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis." European Respiratory Journal 38.6 (2011): 1355-1360. Web. 17 Nov. 2019.

  3. Gaspar, J.

    1. Sandoval, J. et al "Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension." European Respiratory Journal 38.6 (2011): 1343-1348. Web. 17 Nov. 2019.

  4. Ge, Q.

    1. Seidel, P. et al "IκBα glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES." European Respiratory Journal 38.6 (2011): 1444-1452. Web. 17 Nov. 2019.

  5. Gibbs, J.S.R.

    1. Rhodes, C.J. et al "Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target." European Respiratory Journal 38.6 (2011): 1453-1460. Web. 17 Nov. 2019.

  6. Gilchrist, F.J.

    1. Gilchrist, F.J. et al "Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?." European Respiratory Journal 38.6 (2011): 1483-1486. Web. 17 Nov. 2019.

  7. Girard, F.

    1. Nardi, A. et al "Stage IV sarcoidosis: comparison of survival with the general population and causes of death." European Respiratory Journal 38.6 (2011): 1368-1373. Web. 17 Nov. 2019.

  8. Govan, J.R.

    1. Gilchrist, F.J. et al "Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?." European Respiratory Journal 38.6 (2011): 1483-1486. Web. 17 Nov. 2019.

  9. Gruber, W.

    1. Gruber, W., D.M. Orenstein, and K.M. Braumann. "Do responses to exercise training in cystic fibrosis depend on initial fitness level?." European Respiratory Journal 38.6 (2011): 1336-1342. Web. 17 Nov. 2019.

  10. Grunstein, R.R.

    1. Marshall, N.S. et al "Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study." European Respiratory Journal 38.6 (2011): 1349-1354. Web. 17 Nov. 2019.

  11. Guardiola, J.

    1. Moffett, B.K. et al "Computed tomography measurements of parapneumonic effusion indicative of thoracentesis." European Respiratory Journal 38.6 (2011): 1406-1411. Web. 17 Nov. 2019.

  12. Guillem, P.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

H

  1. Hammond, N.

    1. Musk, A.W. et al "Predicting survival in malignant mesothelioma." European Respiratory Journal 38.6 (2011): 1420-1424. Web. 17 Nov. 2019.

  2. Hart, P.H.

    1. Hollams, E.M. et al "Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study." European Respiratory Journal 38.6 (2011): 1320-1327. Web. 17 Nov. 2019.

  3. Hedner, J.

    1. Marshall, N.S. et al "Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study." European Respiratory Journal 38.6 (2011): 1349-1354. Web. 17 Nov. 2019.

  4. Hirakawa, A.

    1. Hirata, T. et al "Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients." European Respiratory Journal 38.6 (2011): 1425-1430. Web. 17 Nov. 2019.

  5. Hirata, T.

    1. Hirata, T. et al "Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients." European Respiratory Journal 38.6 (2011): 1425-1430. Web. 17 Nov. 2019.

  6. Hollams, E.M.

    1. Hollams, E.M. et al "Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study." European Respiratory Journal 38.6 (2011): 1320-1327. Web. 17 Nov. 2019.

  7. Hollo, V.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.
    2. Pimpin, L. et al "Tuberculosis and HIV co-infection in European Union and European Economic Area countries." European Respiratory Journal 38.6 (2011): 1382-1392. Web. 17 Nov. 2019.

  8. Holt, B.J.

    1. Hollams, E.M. et al "Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study." European Respiratory Journal 38.6 (2011): 1320-1327. Web. 17 Nov. 2019.

  9. Holt, P.G.

    1. Hollams, E.M. et al "Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study." European Respiratory Journal 38.6 (2011): 1320-1327. Web. 17 Nov. 2019.

  10. Hop, W.C.J.

    1. Bakker, E.M. et al "Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation." European Respiratory Journal 38.6 (2011): 1328-1335. Web. 17 Nov. 2019.

  11. Howard, L.

    1. Rhodes, C.J. et al "Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target." European Respiratory Journal 38.6 (2011): 1453-1460. Web. 17 Nov. 2019.

  12. Hua-Huy, T.

    1. Tiev, K.P. et al "Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis." European Respiratory Journal 38.6 (2011): 1355-1360. Web. 17 Nov. 2019.

  13. Huitric, E.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.

  14. Huizar, I.

    1. Kavuru, M.S. et al "An open-label trial of rituximab therapy in pulmonary alveolar proteinosis." European Respiratory Journal 38.6 (2011): 1361-1367. Web. 17 Nov. 2019.

I

  1. Isalska, B.

    1. Jones, A.M. et al "Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples." European Respiratory Journal 38.6 (2011): 1486-1487. Web. 17 Nov. 2019.

J

  1. Jain, D.

    1. Joshi, R. et al "Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study." European Respiratory Journal 38.6 (2011): 1475-1477. Web. 17 Nov. 2019.

  2. Jain, V.

    1. Joshi, R. et al "Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study." European Respiratory Journal 38.6 (2011): 1475-1477. Web. 17 Nov. 2019.

  3. Janssen, H-G.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.

  4. Jheon, S.

    1. Park, J.S. et al "EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism." European Respiratory Journal 38.6 (2011): 1480-1482. Web. 17 Nov. 2019.

  5. Jones, A.M.

    1. Gilchrist, F.J. et al "Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?." European Respiratory Journal 38.6 (2011): 1483-1486. Web. 17 Nov. 2019.
    2. Jones, A.M. et al "Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples." European Respiratory Journal 38.6 (2011): 1486-1487. Web. 17 Nov. 2019.

  6. Joos, G.

    1. Gaga, M., G. Joos, and P. Chanez. "Prof. Philippe Godard, 1948–2011." European Respiratory Journal 38.6 (2011): 1248-1249. Web. 17 Nov. 2019.

  7. Joshi, R.

    1. Joshi, R. et al "Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study." European Respiratory Journal 38.6 (2011): 1475-1477. Web. 17 Nov. 2019.

K

  1. Kalantri, S.

    1. Joshi, R. et al "Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study." European Respiratory Journal 38.6 (2011): 1475-1477. Web. 17 Nov. 2019.

  2. Karason, K.

    1. Marshall, N.S. et al "Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study." European Respiratory Journal 38.6 (2011): 1349-1354. Web. 17 Nov. 2019.

  3. Karnekar, R.

    1. Kavuru, M.S. et al "An open-label trial of rituximab therapy in pulmonary alveolar proteinosis." European Respiratory Journal 38.6 (2011): 1361-1367. Web. 17 Nov. 2019.

  4. Katsumata, N.

    1. Hirata, T. et al "Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients." European Respiratory Journal 38.6 (2011): 1425-1430. Web. 17 Nov. 2019.

  5. Katz, J.

    1. Checkley, W. et al "Supplementation with vitamin A early in life and subsequent risk of asthma." European Respiratory Journal 38.6 (2011): 1310-1319. Web. 17 Nov. 2019.

  6. Kavuru, M.S.

    1. Kavuru, M.S. et al "An open-label trial of rituximab therapy in pulmonary alveolar proteinosis." European Respiratory Journal 38.6 (2011): 1361-1367. Web. 17 Nov. 2019.

  7. Kettaneh, A.

    1. Tiev, K.P. et al "Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis." European Respiratory Journal 38.6 (2011): 1355-1360. Web. 17 Nov. 2019.

  8. Khatry, S.

    1. Checkley, W. et al "Supplementation with vitamin A early in life and subsequent risk of asthma." European Respiratory Journal 38.6 (2011): 1310-1319. Web. 17 Nov. 2019.

  9. Kjuus, H.

    1. Nordby, K-C. et al "Exposure to thoracic dust, airway symptoms and lung function in cement production workers." European Respiratory Journal 38.6 (2011): 1278-1286. Web. 17 Nov. 2019.

  10. Knobel, H.H.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.

  11. Ködmön, C.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.
    2. Pimpin, L. et al "Tuberculosis and HIV co-infection in European Union and European Economic Area countries." European Respiratory Journal 38.6 (2011): 1382-1392. Web. 17 Nov. 2019.

  12. Kongerud, J.

    1. Nordby, K-C. et al "Exposure to thoracic dust, airway symptoms and lung function in cement production workers." European Respiratory Journal 38.6 (2011): 1278-1286. Web. 17 Nov. 2019.

  13. Krouwels, F.H.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.

  14. Kruijshaar, M.E.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.
    2. Pimpin, L. et al "Tuberculosis and HIV co-infection in European Union and European Economic Area countries." European Respiratory Journal 38.6 (2011): 1382-1392. Web. 17 Nov. 2019.

L

  1. Lacedonia, D.

    1. Carpagnano, G.E. et al "Microsatellite alterations at 3p and 19q in EBC DNA of smokers: are they reversible after smoking cessation?." European Respiratory Journal 38.6 (2011): 1477-1480. Web. 17 Nov. 2019.

  2. Lantuejoul, S.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

  3. LeClerq, S.C.

    1. Checkley, W. et al "Supplementation with vitamin A early in life and subsequent risk of asthma." European Respiratory Journal 38.6 (2011): 1310-1319. Web. 17 Nov. 2019.

  4. Lee, C-T.

    1. Park, J.S. et al "EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism." European Respiratory Journal 38.6 (2011): 1480-1482. Web. 17 Nov. 2019.

  5. Lee, J.H.

    1. Park, J.S. et al "EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism." European Respiratory Journal 38.6 (2011): 1480-1482. Web. 17 Nov. 2019.

  6. Lee, S.W.

    1. Park, J.S. et al "EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism." European Respiratory Journal 38.6 (2011): 1480-1482. Web. 17 Nov. 2019.

  7. Letoumelin, P.

    1. Nardi, A. et al "Stage IV sarcoidosis: comparison of survival with the general population and causes of death." European Respiratory Journal 38.6 (2011): 1368-1373. Web. 17 Nov. 2019.

  8. Leung, E.

    1. Minion, J. et al "Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis." European Respiratory Journal 38.6 (2011): 1398-1405. Web. 17 Nov. 2019.

  9. Litonjua, A.A.

    1. Weiss, S.T., and A.A. Litonjua. "Vitamin D in asthma and allergy: what next?." European Respiratory Journal 38.6 (2011): 1255-1257. Web. 17 Nov. 2019.

  10. Lockhart, A.

    1. Puchelle, E. et al "Prof. Paul Sadoul, 1918–2011." European Respiratory Journal 38.6 (2011): 1245-1247. Web. 17 Nov. 2019.

  11. Lundbäck, B.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  12. Lutter, R.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.

M

  1. Malur, A.

    1. Kavuru, M.S. et al "An open-label trial of rituximab therapy in pulmonary alveolar proteinosis." European Respiratory Journal 38.6 (2011): 1361-1367. Web. 17 Nov. 2019.

  2. Maly, M.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  3. Manissero, D.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.
    2. Pimpin, L. et al "Tuberculosis and HIV co-infection in European Union and European Economic Area countries." European Respiratory Journal 38.6 (2011): 1382-1392. Web. 17 Nov. 2019.

  4. Marshall, I.

    1. Kavuru, M.S. et al "An open-label trial of rituximab therapy in pulmonary alveolar proteinosis." European Respiratory Journal 38.6 (2011): 1361-1367. Web. 17 Nov. 2019.

  5. Marshall, N.S.

    1. Marshall, N.S. et al "Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study." European Respiratory Journal 38.6 (2011): 1349-1354. Web. 17 Nov. 2019.

  6. Matteelli, A.

    1. Pontali, E. et al "Tuberculosis and HIV co-infection: do we have a surveillance system in Europe?." European Respiratory Journal 38.6 (2011): 1258-1260. Web. 17 Nov. 2019.

  7. Menzies, D.

    1. Minion, J. et al "Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis." European Respiratory Journal 38.6 (2011): 1398-1405. Web. 17 Nov. 2019.

  8. Meren, M.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  9. Merfort, I.

    1. Seidel, P. et al "IκBα glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES." European Respiratory Journal 38.6 (2011): 1444-1452. Web. 17 Nov. 2019.

  10. Merkus, P.J.F.M.

    1. Bakker, E.M. et al "Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation." European Respiratory Journal 38.6 (2011): 1328-1335. Web. 17 Nov. 2019.

  11. Mets, O.M.

    1. van Zeggeren, L. et al "High-resolution computed tomography and pulmonary function in children with common variable immunodeficiency." European Respiratory Journal 38.6 (2011): 1437-1443. Web. 17 Nov. 2019.

  12. Meziane, M.

    1. Kavuru, M.S. et al "An open-label trial of rituximab therapy in pulmonary alveolar proteinosis." European Respiratory Journal 38.6 (2011): 1361-1367. Web. 17 Nov. 2019.

  13. Migliori, G.B.

    1. Pontali, E. et al "Tuberculosis and HIV co-infection: do we have a surveillance system in Europe?." European Respiratory Journal 38.6 (2011): 1258-1260. Web. 17 Nov. 2019.

  14. Mina, R.

    1. Musk, A.W. et al "Predicting survival in malignant mesothelioma." European Respiratory Journal 38.6 (2011): 1420-1424. Web. 17 Nov. 2019.

  15. Minion, J.

    1. Minion, J. et al "Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis." European Respiratory Journal 38.6 (2011): 1398-1405. Web. 17 Nov. 2019.

  16. Moffett, B.K.

    1. Moffett, B.K. et al "Computed tomography measurements of parapneumonic effusion indicative of thoracentesis." European Respiratory Journal 38.6 (2011): 1406-1411. Web. 17 Nov. 2019.

  17. Morawiec, E.

    1. Morawiec, E. et al "Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses." European Respiratory Journal 38.6 (2011): 1487-1489. Web. 17 Nov. 2019.

  18. Moraza, J.

    1. Esteban, C. et al "Development of a decision tree to assess the severity and prognosis of stable COPD." European Respiratory Journal 38.6 (2011): 1294-1300. Web. 17 Nov. 2019.

  19. Moro-Sibilot, D.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

  20. Musk, A.W.

    1. Musk, A.W. et al "Predicting survival in malignant mesothelioma." European Respiratory Journal 38.6 (2011): 1420-1424. Web. 17 Nov. 2019.

  21. Mutton, K.

    1. Jones, A.M. et al "Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples." European Respiratory Journal 38.6 (2011): 1486-1487. Web. 17 Nov. 2019.

N

  1. Naccache, J-M.

    1. Nardi, A. et al "Stage IV sarcoidosis: comparison of survival with the general population and causes of death." European Respiratory Journal 38.6 (2011): 1368-1373. Web. 17 Nov. 2019.

  2. Nagy-Mignotte, H.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

  3. Nakamatsu, R.

    1. Moffett, B.K. et al "Computed tomography measurements of parapneumonic effusion indicative of thoracentesis." European Respiratory Journal 38.6 (2011): 1406-1411. Web. 17 Nov. 2019.

  4. Narang, U.

    1. Joshi, R. et al "Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study." European Respiratory Journal 38.6 (2011): 1475-1477. Web. 17 Nov. 2019.

  5. Nardi, A.

    1. Nardi, A. et al "Stage IV sarcoidosis: comparison of survival with the general population and causes of death." European Respiratory Journal 38.6 (2011): 1368-1373. Web. 17 Nov. 2019.

  6. Nordby, K-C.

    1. Nordby, K-C. et al "Exposure to thoracic dust, airway symptoms and lung function in cement production workers." European Respiratory Journal 38.6 (2011): 1278-1286. Web. 17 Nov. 2019.

  7. Notø, H.

    1. Nordby, K-C. et al "Exposure to thoracic dust, airway symptoms and lung function in cement production workers." European Respiratory Journal 38.6 (2011): 1278-1286. Web. 17 Nov. 2019.

  8. Nunes, H.

    1. Nardi, A. et al "Stage IV sarcoidosis: comparison of survival with the general population and causes of death." European Respiratory Journal 38.6 (2011): 1368-1373. Web. 17 Nov. 2019.

O

  1. Olsen, N.

    1. Musk, A.W. et al "Predicting survival in malignant mesothelioma." European Respiratory Journal 38.6 (2011): 1420-1424. Web. 17 Nov. 2019.

  2. Orenstein, D.M.

    1. Gruber, W., D.M. Orenstein, and K.M. Braumann. "Do responses to exercise training in cystic fibrosis depend on initial fitness level?." European Respiratory Journal 38.6 (2011): 1336-1342. Web. 17 Nov. 2019.

P

  1. Pai, M.

    1. Whitelaw, A. et al "Comparative cost and performance of light-emitting diode microscopy in HIV–tuberculosis-co-infected patients." European Respiratory Journal 38.6 (2011): 1393-1397. Web. 17 Nov. 2019.
    2. Minion, J. et al "Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis." European Respiratory Journal 38.6 (2011): 1398-1405. Web. 17 Nov. 2019.
    3. Joshi, R. et al "Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study." European Respiratory Journal 38.6 (2011): 1475-1477. Web. 17 Nov. 2019.

  2. Palladino, G.P.

    1. Carpagnano, G.E. et al "Microsatellite alterations at 3p and 19q in EBC DNA of smokers: are they reversible after smoking cessation?." European Respiratory Journal 38.6 (2011): 1477-1480. Web. 17 Nov. 2019.

  3. Panchabhai, T.S.

    1. Moffett, B.K. et al "Computed tomography measurements of parapneumonic effusion indicative of thoracentesis." European Respiratory Journal 38.6 (2011): 1406-1411. Web. 17 Nov. 2019.

  4. Pansini, V.

    1. Morawiec, E. et al "Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses." European Respiratory Journal 38.6 (2011): 1487-1489. Web. 17 Nov. 2019.

  5. Park, J.S.

    1. Park, J.S. et al "EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism." European Respiratory Journal 38.6 (2011): 1480-1482. Web. 17 Nov. 2019.

  6. Parsons, F.

    1. Hollams, E.M. et al "Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study." European Respiratory Journal 38.6 (2011): 1320-1327. Web. 17 Nov. 2019.

  7. Pasticci, M.B.

    1. Pontali, E. et al "Tuberculosis and HIV co-infection: do we have a surveillance system in Europe?." European Respiratory Journal 38.6 (2011): 1258-1260. Web. 17 Nov. 2019.

  8. Peltonen, M.

    1. Marshall, N.S. et al "Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study." European Respiratory Journal 38.6 (2011): 1349-1354. Web. 17 Nov. 2019.

  9. Peña, H.

    1. Sandoval, J. et al "Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension." European Respiratory Journal 38.6 (2011): 1343-1348. Web. 17 Nov. 2019.

  10. Peng, C.H.

    1. Zong, Z.Y., and C.H. Peng. "Ralstonia mannitolilytica and COPD: a case report." European Respiratory Journal 38.6 (2011): 1482-1483. Web. 17 Nov. 2019.

  11. Perez, T.

    1. Perez, T.. "Is it really time to look at distal airways to improve asthma phenotyping and treatment?." European Respiratory Journal 38.6 (2011): 1252-1254. Web. 17 Nov. 2019.

  12. Pérez-Izquierdo, J.

    1. Esteban, C. et al "Development of a decision tree to assess the severity and prognosis of stable COPD." European Respiratory Journal 38.6 (2011): 1294-1300. Web. 17 Nov. 2019.

  13. Peter, J.

    1. Whitelaw, A. et al "Comparative cost and performance of light-emitting diode microscopy in HIV–tuberculosis-co-infected patients." European Respiratory Journal 38.6 (2011): 1393-1397. Web. 17 Nov. 2019.

  14. Peters, S.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.

  15. Peyrani, P.

    1. Moffett, B.K. et al "Computed tomography measurements of parapneumonic effusion indicative of thoracentesis." European Respiratory Journal 38.6 (2011): 1406-1411. Web. 17 Nov. 2019.

  16. Pimpin, L.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.
    2. Pimpin, L. et al "Tuberculosis and HIV co-infection in European Union and European Economic Area countries." European Respiratory Journal 38.6 (2011): 1382-1392. Web. 17 Nov. 2019.

  17. Pistelli, F.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  18. Pontali, E.

    1. Pontali, E. et al "Tuberculosis and HIV co-infection: do we have a surveillance system in Europe?." European Respiratory Journal 38.6 (2011): 1258-1260. Web. 17 Nov. 2019.

  19. Puchelle, E.

    1. Puchelle, E. et al "Prof. Paul Sadoul, 1918–2011." European Respiratory Journal 38.6 (2011): 1245-1247. Web. 17 Nov. 2019.

  20. Pulido, T.

    1. Sandoval, J. et al "Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension." European Respiratory Journal 38.6 (2011): 1343-1348. Web. 17 Nov. 2019.

Q

  1. Quanjer, P.H.

    1. Puchelle, E. et al "Prof. Paul Sadoul, 1918–2011." European Respiratory Journal 38.6 (2011): 1245-1247. Web. 17 Nov. 2019.

  2. Quintana, J.M.

    1. Esteban, C. et al "Development of a decision tree to assess the severity and prognosis of stable COPD." European Respiratory Journal 38.6 (2011): 1294-1300. Web. 17 Nov. 2019.

R

  1. Ramirez, J.A.

    1. Moffett, B.K. et al "Computed tomography measurements of parapneumonic effusion indicative of thoracentesis." European Respiratory Journal 38.6 (2011): 1406-1411. Web. 17 Nov. 2019.

  2. Reid, A.

    1. Musk, A.W. et al "Predicting survival in malignant mesothelioma." European Respiratory Journal 38.6 (2011): 1420-1424. Web. 17 Nov. 2019.

  3. Remy-Jardin, M.

    1. Morawiec, E. et al "Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses." European Respiratory Journal 38.6 (2011): 1487-1489. Web. 17 Nov. 2019.

  4. Rhodes, C.J.

    1. Rhodes, C.J. et al "Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target." European Respiratory Journal 38.6 (2011): 1453-1460. Web. 17 Nov. 2019.

  5. Rice, B.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.
    2. Pimpin, L. et al "Tuberculosis and HIV co-infection in European Union and European Economic Area countries." European Respiratory Journal 38.6 (2011): 1382-1392. Web. 17 Nov. 2019.

  6. Riley, D.

    1. Jones, A.M. et al "Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples." European Respiratory Journal 38.6 (2011): 1486-1487. Web. 17 Nov. 2019.

  7. Rodríguez, A.

    1. Sandoval, J. et al "Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension." European Respiratory Journal 38.6 (2011): 1343-1348. Web. 17 Nov. 2019.

  8. Rönmark, E.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  9. Roth, M.

    1. Seidel, P. et al "IκBα glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES." European Respiratory Journal 38.6 (2011): 1444-1452. Web. 17 Nov. 2019.

S

  1. S’ng, C.T.

    1. Seidel, P. et al "IκBα glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES." European Respiratory Journal 38.6 (2011): 1444-1452. Web. 17 Nov. 2019.

  2. Saglani, S.

    1. Sonnappa, S. et al "Relationship between past airway pathology and current lung function in preschool wheezers." European Respiratory Journal 38.6 (2011): 1431-1436. Web. 17 Nov. 2019.

  3. Salleron, J.

    1. Morawiec, E. et al "Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses." European Respiratory Journal 38.6 (2011): 1487-1489. Web. 17 Nov. 2019.

  4. Salonini, E.

    1. Bakker, E.M. et al "Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation." European Respiratory Journal 38.6 (2011): 1328-1335. Web. 17 Nov. 2019.

  5. Sandoval, J.

    1. Sandoval, J. et al "Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension." European Respiratory Journal 38.6 (2011): 1343-1348. Web. 17 Nov. 2019.

  6. Santos, L.E.

    1. Sandoval, J. et al "Effect of atrial septostomy on the survival of patients with severe pulmonary arterial hypertension." European Respiratory Journal 38.6 (2011): 1343-1348. Web. 17 Nov. 2019.

  7. Sardella, A.

    1. Van Miert, E., A. Sardella, and A. Bernard. "Biomarkers of early respiratory effects in smoking adolescents." European Respiratory Journal 38.6 (2011): 1287-1293. Web. 17 Nov. 2019.

  8. Seidel, P.

    1. Seidel, P. et al "IκBα glutathionylation and reduced histone H3 phosphorylation inhibit eotaxin and RANTES." European Respiratory Journal 38.6 (2011): 1444-1452. Web. 17 Nov. 2019.

  9. Serralha, M.

    1. Hollams, E.M. et al "Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study." European Respiratory Journal 38.6 (2011): 1320-1327. Web. 17 Nov. 2019.

  10. Shilkin, K.B.

    1. Musk, A.W. et al "Predicting survival in malignant mesothelioma." European Respiratory Journal 38.6 (2011): 1420-1424. Web. 17 Nov. 2019.

  11. Shimizu, C.

    1. Hirata, T. et al "Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients." European Respiratory Journal 38.6 (2011): 1425-1430. Web. 17 Nov. 2019.

  12. Sintnicolaas, C.J.J.C.M.

    1. Bakker, E.M. et al "Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation." European Respiratory Journal 38.6 (2011): 1328-1335. Web. 17 Nov. 2019.

  13. Sjöström, C.D.

    1. Marshall, N.S. et al "Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study." European Respiratory Journal 38.6 (2011): 1349-1354. Web. 17 Nov. 2019.

  14. Sjöström, L.

    1. Marshall, N.S. et al "Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study." European Respiratory Journal 38.6 (2011): 1349-1354. Web. 17 Nov. 2019.

  15. Skogstad, M.

    1. Nordby, K-C. et al "Exposure to thoracic dust, airway symptoms and lung function in cement production workers." European Respiratory Journal 38.6 (2011): 1278-1286. Web. 17 Nov. 2019.

  16. Sleith, J.

    1. Musk, A.W. et al "Predicting survival in malignant mesothelioma." European Respiratory Journal 38.6 (2011): 1420-1424. Web. 17 Nov. 2019.

  17. Sly, P.D.

    1. Hollams, E.M. et al "Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study." European Respiratory Journal 38.6 (2011): 1320-1327. Web. 17 Nov. 2019.

  18. Sohn, H.

    1. Whitelaw, A. et al "Comparative cost and performance of light-emitting diode microscopy in HIV–tuberculosis-co-infected patients." European Respiratory Journal 38.6 (2011): 1393-1397. Web. 17 Nov. 2019.

  19. Sommer, A.

    1. Checkley, W. et al "Supplementation with vitamin A early in life and subsequent risk of asthma." European Respiratory Journal 38.6 (2011): 1310-1319. Web. 17 Nov. 2019.

  20. Sonnappa, S.

    1. Sonnappa, S. et al "Relationship between past airway pathology and current lung function in preschool wheezers." European Respiratory Journal 38.6 (2011): 1431-1436. Web. 17 Nov. 2019.

  21. Stenlöf, K.

    1. Marshall, N.S. et al "Self-reported sleep apnoea and mortality in patients from the Swedish Obese Subjects study." European Respiratory Journal 38.6 (2011): 1349-1354. Web. 17 Nov. 2019.

  22. Sterk, P.J.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.

T

  1. Talbot, E.

    1. Minion, J. et al "Diagnosing tuberculosis with urine lipoarabinomannan: systematic review and meta-analysis." European Respiratory Journal 38.6 (2011): 1398-1405. Web. 17 Nov. 2019.

  2. Tamura, K.

    1. Hirata, T. et al "Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients." European Respiratory Journal 38.6 (2011): 1425-1430. Web. 17 Nov. 2019.

  3. Tanimoto, M.

    1. Hirata, T. et al "Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients." European Respiratory Journal 38.6 (2011): 1425-1430. Web. 17 Nov. 2019.

  4. Terheggen-Lagro, S.W.J.

    1. van Zeggeren, L. et al "High-resolution computed tomography and pulmonary function in children with common variable immunodeficiency." European Respiratory Journal 38.6 (2011): 1437-1443. Web. 17 Nov. 2019.

  5. Theron, G.

    1. Whitelaw, A. et al "Comparative cost and performance of light-emitting diode microscopy in HIV–tuberculosis-co-infected patients." European Respiratory Journal 38.6 (2011): 1393-1397. Web. 17 Nov. 2019.

  6. Thickett, D.R.

    1. Dancer, R.C.A., A.M. Wood, and D.R. Thickett. "Metalloproteinases in idiopathic pulmonary fibrosis." European Respiratory Journal 38.6 (2011): 1461-1467. Web. 17 Nov. 2019.

  7. Thomassen, M.J.

    1. Kavuru, M.S. et al "An open-label trial of rituximab therapy in pulmonary alveolar proteinosis." European Respiratory Journal 38.6 (2011): 1361-1367. Web. 17 Nov. 2019.

  8. Thomassen, Y.

    1. Nordby, K-C. et al "Exposure to thoracic dust, airway symptoms and lung function in cement production workers." European Respiratory Journal 38.6 (2011): 1278-1286. Web. 17 Nov. 2019.

  9. Threlfall, T.

    1. Musk, A.W. et al "Predicting survival in malignant mesothelioma." European Respiratory Journal 38.6 (2011): 1420-1424. Web. 17 Nov. 2019.

  10. Tiddens, H.A.W.M.

    1. Bakker, E.M. et al "Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation." European Respiratory Journal 38.6 (2011): 1328-1335. Web. 17 Nov. 2019.

  11. Tielsch, J.M.

    1. Checkley, W. et al "Supplementation with vitamin A early in life and subsequent risk of asthma." European Respiratory Journal 38.6 (2011): 1310-1319. Web. 17 Nov. 2019.

  12. Tiev, K.P.

    1. Tiev, K.P. et al "Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis." European Respiratory Journal 38.6 (2011): 1355-1360. Web. 17 Nov. 2019.

  13. Tillie-Leblond, I.

    1. Morawiec, E. et al "Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses." European Respiratory Journal 38.6 (2011): 1487-1489. Web. 17 Nov. 2019.

  14. Timsit, J.F.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

  15. Toffart, A.C.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

  16. Tolédano, C.

    1. Tiev, K.P. et al "Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis." European Respiratory Journal 38.6 (2011): 1355-1360. Web. 17 Nov. 2019.

U

  1. Uzunhan, Y.

    1. Nardi, A. et al "Stage IV sarcoidosis: comparison of survival with the general population and causes of death." European Respiratory Journal 38.6 (2011): 1368-1373. Web. 17 Nov. 2019.

V

  1. Valeyre, D.

    1. Nardi, A. et al "Stage IV sarcoidosis: comparison of survival with the general population and causes of death." European Respiratory Journal 38.6 (2011): 1368-1373. Web. 17 Nov. 2019.

  2. van de Laar, M.

    1. Kruijshaar, M.E. et al "The burden of TB–HIV in the EU: how much do we know? A survey of surveillance practices and results." European Respiratory Journal 38.6 (2011): 1374-1381. Web. 17 Nov. 2019.

  3. van der Wiel-Kooij, E.C.

    1. Bakker, E.M. et al "Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation." European Respiratory Journal 38.6 (2011): 1328-1335. Web. 17 Nov. 2019.

  4. van de Ven, A.A.J.M.

    1. van Zeggeren, L. et al "High-resolution computed tomography and pulmonary function in children with common variable immunodeficiency." European Respiratory Journal 38.6 (2011): 1437-1443. Web. 17 Nov. 2019.

  5. Van Miert, E.

    1. Van Miert, E., A. Sardella, and A. Bernard. "Biomarkers of early respiratory effects in smoking adolescents." European Respiratory Journal 38.6 (2011): 1287-1293. Web. 17 Nov. 2019.

  6. van Montfrans, J.M.

    1. van Zeggeren, L. et al "High-resolution computed tomography and pulmonary function in children with common variable immunodeficiency." European Respiratory Journal 38.6 (2011): 1437-1443. Web. 17 Nov. 2019.

  7. van Zeggeren, L.

    1. van Zeggeren, L. et al "High-resolution computed tomography and pulmonary function in children with common variable immunodeficiency." European Respiratory Journal 38.6 (2011): 1437-1443. Web. 17 Nov. 2019.

  8. Vermeire†, P.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  9. Vesin, A.

    1. Nagy-Mignotte, H. et al "Primary lung adenocarcinoma: characteristics by smoking habit and sex." European Respiratory Journal 38.6 (2011): 1412-1419. Web. 17 Nov. 2019.

  10. Vestbo, J.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  11. Viegi, G.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  12. Viljoen, D.

    1. Whitelaw, A. et al "Comparative cost and performance of light-emitting diode microscopy in HIV–tuberculosis-co-infected patients." European Respiratory Journal 38.6 (2011): 1393-1397. Web. 17 Nov. 2019.

  13. Vink, T.J.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.

  14. Volpi, S.

    1. Bakker, E.M. et al "Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation." European Respiratory Journal 38.6 (2011): 1328-1335. Web. 17 Nov. 2019.

  15. Vonk-Noordegraaf, A.

    1. Rhodes, C.J. et al "Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target." European Respiratory Journal 38.6 (2011): 1453-1460. Web. 17 Nov. 2019.

W

  1. Wallaert, B.

    1. Morawiec, E. et al "Exacerbations of idiopathic pulmonary fibrosis treated with corticosteroids and cyclophosphamide pulses." European Respiratory Journal 38.6 (2011): 1487-1489. Web. 17 Nov. 2019.

  2. Webb, A.K.

    1. Gilchrist, F.J. et al "Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?." European Respiratory Journal 38.6 (2011): 1483-1486. Web. 17 Nov. 2019.

  3. Webb, K.

    1. Jones, A.M. et al "Diagnosis of respiratory viral infections in cystic fibrosis by PCR using sputum samples." European Respiratory Journal 38.6 (2011): 1486-1487. Web. 17 Nov. 2019.

  4. Weiss, S.T.

    1. Weiss, S.T., and A.A. Litonjua. "Vitamin D in asthma and allergy: what next?." European Respiratory Journal 38.6 (2011): 1255-1257. Web. 17 Nov. 2019.

  5. Wempe, J.B.

    1. Wijkstra, P.J., and J.B. Wempe. "New tools in pulmonary rehabilitation." European Respiratory Journal 38.6 (2011): 1468-1474. Web. 17 Nov. 2019.

  6. West, K.P.

    1. Checkley, W. et al "Supplementation with vitamin A early in life and subsequent risk of asthma." European Respiratory Journal 38.6 (2011): 1310-1319. Web. 17 Nov. 2019.

  7. Wharton, J.

    1. Rhodes, C.J. et al "Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target." European Respiratory Journal 38.6 (2011): 1453-1460. Web. 17 Nov. 2019.

  8. Whitelaw, A.

    1. Whitelaw, A. et al "Comparative cost and performance of light-emitting diode microscopy in HIV–tuberculosis-co-infected patients." European Respiratory Journal 38.6 (2011): 1393-1397. Web. 17 Nov. 2019.

  9. Widimsky, J.

    1. Puchelle, E. et al "Prof. Paul Sadoul, 1918–2011." European Respiratory Journal 38.6 (2011): 1245-1247. Web. 17 Nov. 2019.

  10. Wiemken, T.

    1. Moffett, B.K. et al "Computed tomography measurements of parapneumonic effusion indicative of thoracentesis." European Respiratory Journal 38.6 (2011): 1406-1411. Web. 17 Nov. 2019.

  11. Wijkstra, P.J.

    1. Wijkstra, P.J., and J.B. Wempe. "New tools in pulmonary rehabilitation." European Respiratory Journal 38.6 (2011): 1468-1474. Web. 17 Nov. 2019.

  12. Wilkins, M.R.

    1. Rhodes, C.J. et al "Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target." European Respiratory Journal 38.6 (2011): 1453-1460. Web. 17 Nov. 2019.

  13. Willard, N.P.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.

  14. Wise, R.A.

    1. Checkley, W. et al "Supplementation with vitamin A early in life and subsequent risk of asthma." European Respiratory Journal 38.6 (2011): 1310-1319. Web. 17 Nov. 2019.

  15. Wood, A.M.

    1. Dancer, R.C.A., A.M. Wood, and D.R. Thickett. "Metalloproteinases in idiopathic pulmonary fibrosis." European Respiratory Journal 38.6 (2011): 1461-1467. Web. 17 Nov. 2019.

  16. Woodhead, M.

    1. Woodhead, M.. "New guidelines for the management of adult lower respiratory tract infections." European Respiratory Journal 38.6 (2011): 1250-1251. Web. 17 Nov. 2019.

  17. Wu, L.

    1. Checkley, W. et al "Supplementation with vitamin A early in life and subsequent risk of asthma." European Respiratory Journal 38.6 (2011): 1310-1319. Web. 17 Nov. 2019.

Y

  1. Yonemori, K.

    1. Hirata, T. et al "Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients." European Respiratory Journal 38.6 (2011): 1425-1430. Web. 17 Nov. 2019.

  2. Yoon, H.I.

    1. Park, J.S. et al "EBUS-TBNA in the differential diagnosis of pulmonary artery sarcoma and thromboembolism." European Respiratory Journal 38.6 (2011): 1480-1482. Web. 17 Nov. 2019.

Z

  1. Zhang, G.

    1. Hollams, E.M. et al "Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study." European Respiratory Journal 38.6 (2011): 1320-1327. Web. 17 Nov. 2019.

  2. Zielinski, J.

    1. Bakke, P.S. et al "Recommendations for epidemiological studies on COPD." European Respiratory Journal 38.6 (2011): 1261-1277. Web. 17 Nov. 2019.

  3. Zong, Z.Y.

    1. Zong, Z.Y., and C.H. Peng. "Ralstonia mannitolilytica and COPD: a case report." European Respiratory Journal 38.6 (2011): 1482-1483. Web. 17 Nov. 2019.

  4. Zwerling, A.

    1. Joshi, R. et al "Predictive value of latent tuberculosis tests in Indian healthcare workers: a cohort study." European Respiratory Journal 38.6 (2011): 1475-1477. Web. 17 Nov. 2019.

  5. Zwinderman, A.H.

    1. Fens, N. et al "Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD." European Respiratory Journal 38.6 (2011): 1301-1309. Web. 17 Nov. 2019.
Back to top
European Respiratory Journal: 38 (6)

Search Within This Issue

Jump to

Manage Table of content Alerts